The Star-Ledger’s recent editorial, “Drug prices are obscene, and (Gov. Phil) Murphy is blocking the smart solution,” left out key facts regarding the role of drug manufacturers in determining what patients pay for name-brand medicines. …
Trenton, July 29, 2022 ― Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning
Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning recent discussions in Washington on potential drug pricing legislation.
Dean J. Paranicas, President and Chief Executive Officer of the HealthCare Institute of New Jersey, released the following statement concerning recent discussions in Washington on potential drug pricing legislation in a reconciliation package.
The HealthCare Institute of New Jersey (HINJ) has announced new officers of its Board of Trustees and the leadership of its Steering Committee, effective July 1.
An op-ed by Dean J. Paranicas, HINJ President and Chief Executive Officer (Published in the print edition of the Asbury Park Press on Friday, May
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
